Since May 2020
AUM managed
₹1,27,855.01Cr
Tenure
Since May 2020
Funds
12
NAV
₹41.28
+0.10% today
AUM
₹6,995.62 Cr
Fund size
Expense
2.09%
Regular plan
Min SIP
₹100
per month
Min Lumpsum
₹5,000
one-time
Exit Load
1.0
on redemption
STCG · short-term
20%Short-term gains taxed at 20%
Applies when equity fund units are sold within 12 months.
LTCG · long-term
12.5%Long-term gains taxed at 12.5%
Applies when equity fund units are sold after 12 months.
Equity-oriented mutual fund taxation applies based on holding period.
Since May 2020
AUM managed
₹1,27,855.01Cr
Tenure
Since May 2020
Funds
12
Since Jul 2022
AUM managed
₹7,38,305.11Cr
Tenure
Since Jul 2022
Funds
54
ICICI Pru Pharma Healthcare Diag Gr is an open-ended Sector - Healthcare mutual fund scheme offered by ICICI Prudential Mutual Fund under the regular plan with the growth option. Its latest net asset value (NAV) is ₹41.28 per unit and the scheme manages ₹6,995.62 Cr in assets under management. The fund charges an expense ratio of 2.09% and is benchmarked against BSE Healthcare TR INR (100%). Over the trailing 5 years, ICICI Pru Pharma Healthcare Diag Gr has delivered +14.03% returns. SEBI's riskometer places this scheme in the Very High Risk category, so read the scheme information document before investing.
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Regular Plan · Growth option · NAV as of 15 Oct 2026
| Period | Fund | Category average |
|---|---|---|
| 1 month | -2.39% | -5.83% |
| 3 months | -5.82% | -3.41% |
| 6 months | +7.78% | +13.35% |
| 1 year | +3.02% | +10.74% |
| 3 years | +19.42% | +19.18% |
| 5 years | +14.03% | +12.83% |
| Period | Fund | Category average |
|---|---|---|
| 1 month | -- | -3.44% |
| 3 months | +6.04% | +1.95% |
| 6 months | +13.96% | +19.58% |
| 1 year | +10.80% | +17.08% |
| 3 years | +85.04% | +73.64% |
| 5 years | +108.01% | +91.32% |
Past performance is not indicative of future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.
The latest net asset value (NAV) of ICICI Pru Pharma Healthcare Diag Gr is ₹41.28 per unit, +0.10% over the previous trading day. NAV is declared by the AMC at the end of every business day.
ICICI Pru Pharma Healthcare Diag Gr has returned +14.03% over the trailing 5 years (1 year: +3.02%, 3 years: +19.42%). Returns beyond one year are annualised. Past performance does not guarantee future returns.
ICICI Pru Pharma Healthcare Diag Gr charges an expense ratio of 2.09% per annum. The expense ratio is deducted from the scheme's assets, so the NAV you see is already net of it.
SEBI's riskometer classifies ICICI Pru Pharma Healthcare Diag Gr as Very High Risk, which is typical for a Sector - Healthcare scheme. Match the scheme's risk level to your own risk tolerance and investment horizon before investing.
You can start a SIP in ICICI Pru Pharma Healthcare Diag Gr from ₹100 per month, and the minimum lumpsum investment is ₹5,000.
ICICI Pru Pharma Healthcare Diag Gr is managed by ICICI Prudential Mutual Fund, holds ₹6,995.62 Cr in assets under management and invests across 35 holdings. This page covers the regular plan with the growth option.
We use cookies
We use cookies to help this site function, understand service usage, and support marketing efforts. Cookie Policy ·